Camylofin
Top View
- Council of Europe Committee of Ministers (Partial
- WO 2012/059936 Al
- Hyoscine Butylbromide for Cervical Rigidity In
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
- Camylofin Dihydrochloride Injection: a Drug Monograph Review
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Muscarinic Acetylcholine Receptor
- Customs Tariff - Schedule Xxi - 1
- Preference Trends for Antispasmodics Among Indian Healthcare Professionals: Results of a Cross Sectional Survey
- The Pharmacy and Drugs Act, 2001
- The Effect of Hyoscine N- Butylbromide On
- Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
- (12) United States Patent (10) Patent No.: US 9.474,719 B2 Mullen Et Al
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Figure S1. Rhod 2 Staining of Intracellular Calcium Depletion
- (Finished Products) for All Therapeutic Categories